This page contains a Flash digital edition of a book.
| RobERT DAnIEls | pEOpLE pROfILE


point, with a growing understanding of biology, the skin, and knowing how to better heal our patients. 'on the back of 20 years' research by


Professor Weiss’ Elastin laboratory at the University of sydney, we have been able to produce an elastin-based protein at a clinical grade and on a commercial scale,' says Robert. 'The next challenge was to formulate


products to treat the indications we wanted; the obvious starting point was dermatology, a focus driven by clinicians and those who had watched the scientific development of the product.' by applying the product — now named


Elastatherapy — to the right areas of the skin, the team at Elastagen hope to repair damaged skin with functional elastic tissue. The Elastatherapy product range is comprised of tropoelastin, the building block of elastin, and has the potential to either bulk the skin or rejuvenate and restore elasticity to skin tissue to improve its suppleness. 'It is a novel therapy in that the


treatment is based entirely on synthetic human elastin, cross-linked with a minor hyaluronic acid component. There is no requirement for the toxic cross-linking agents often used in other products.' The elastin treatment will also


stimulate skin cells to grow and lead to the formation of new collagen at the treatment site. In fact, you can address a number of


ageing skin issues with just this one product, and at the same time improve the properties of the skin.


Continuing focus Despite such a huge breakthrough for Elastagen and the development of Elastatherapy, Robert asserts that it is imperative for the company to remain focused. For the past 3 years, Robert and his


team at Elastagen have focused on their products and the positioning of the company. now, as they complete their second and third clinical studies, which are showing excellent results, the company hopes to achieve CE mark and introduce the Elastatherapy products to the European market in late 2012. 'I think that Europe has a long history


in the development of new products and treatments in the aesthetic market and the rest of the world has tended to follow,' Robert explains.


'Going forward, it's important to look


at different treatment approaches and measure outcomes to more accurately understand the benefits of elastin to the skin. The best way to maximise the potential of the elastin treatments is the next challenge we face.'


Conclusions The future of aesthetic medicine is certainly exciting when one considers the development and introduction of innovative new products like Elastatherapy, but it is important to rise to the challenge and understand what patients and clinicians want. Robert thinks that this development of the


market will continue to go further beyond hyaluronic acid-based products. 'We've got to look beyond the obvious


and understand where the market is heading, and what patients and doctors are really looking for in an aesthetic treatment. There are also huge differences in attitudes worldwide, and it's important to understand and adapt to these different needs.'


Further information www.elastagen.com


prime-journal.com | October 2011





61


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84